Surgery Plus Reduced Target Chemoradiotherapy vs Surgery Plus Reduced Dose Chemoradiotherapy for Newly Diagnosed Operable Nasopharyngeal Carcinoma.

NARecruitingINTERVENTIONAL
Enrollment

384

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

November 1, 2032

Study Completion Date

November 1, 2032

Conditions
Nasopharyngeal Carcinoma
Interventions
RADIATION

Surgery combined with Target-reduction intensity-modulated radiotherapy

in control arm

RADIATION

Surgery combined with Dose-reduction intensity-modulated radiotherapy

in experimental arm

Trial Locations (1)

519000

RECRUITING

The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai

All Listed Sponsors
collaborator

Fifth Affiliated Hospital, Sun Yat-Sen University

OTHER

collaborator

Sun Yat-sen University

OTHER

collaborator

Fifth Affiliated Hospital of Guangzhou Medical University

OTHER

collaborator

Huazhong University of Science and Technology Union Hospital (Nanshan Hospital)

UNKNOWN

collaborator

The First Affiliated Hospital of University of South China

OTHER

collaborator

People's Hospital of Guangxi Zhuang Autonomous Region

OTHER

collaborator

Nanchang City First Hospital

UNKNOWN

lead

Ming-Yuan Chen

OTHER